On Friday, the Food and Drug Administration (FDA) approved new warnings about an increased risk of blood clots and of death with the 10 mg twice daily dose of Xeljanz, Xeljanz XR (tofacitinib), which is...

The US Food and Drug Administration (FDA) issued a safety alert today concerning the dosing of the rheumatoid arthritis (RA) drug, Xeljanz and Xeljanz XR. A safety clinical trial found an increased risk...